1. Home
  2. SSP vs MDWD Comparison

SSP vs MDWD Comparison

Compare SSP & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSP
  • MDWD
  • Stock Information
  • Founded
  • SSP 1878
  • MDWD 2000
  • Country
  • SSP United States
  • MDWD Israel
  • Employees
  • SSP N/A
  • MDWD N/A
  • Industry
  • SSP Broadcasting
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • SSP Industrials
  • MDWD Health Care
  • Exchange
  • SSP Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • SSP 173.3M
  • MDWD 179.1M
  • IPO Year
  • SSP 1988
  • MDWD 2014
  • Fundamental
  • Price
  • SSP $1.97
  • MDWD $17.80
  • Analyst Decision
  • SSP Buy
  • MDWD Strong Buy
  • Analyst Count
  • SSP 2
  • MDWD 1
  • Target Price
  • SSP $7.75
  • MDWD $28.00
  • AVG Volume (30 Days)
  • SSP 564.8K
  • MDWD 60.7K
  • Earning Date
  • SSP 11-01-2024
  • MDWD 08-14-2024
  • Dividend Yield
  • SSP N/A
  • MDWD N/A
  • EPS Growth
  • SSP N/A
  • MDWD N/A
  • EPS
  • SSP N/A
  • MDWD N/A
  • Revenue
  • SSP $2,317,391,000.00
  • MDWD $20,141,000.00
  • Revenue This Year
  • SSP $8.99
  • MDWD $30.16
  • Revenue Next Year
  • SSP N/A
  • MDWD $18.44
  • P/E Ratio
  • SSP N/A
  • MDWD N/A
  • Revenue Growth
  • SSP N/A
  • MDWD N/A
  • 52 Week Low
  • SSP $1.68
  • MDWD $7.45
  • 52 Week High
  • SSP $9.35
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • SSP 40.78
  • MDWD 50.02
  • Support Level
  • SSP $1.68
  • MDWD $16.25
  • Resistance Level
  • SSP $2.19
  • MDWD $17.90
  • Average True Range (ATR)
  • SSP 0.13
  • MDWD 0.97
  • MACD
  • SSP 0.03
  • MDWD -0.05
  • Stochastic Oscillator
  • SSP 40.48
  • MDWD 36.98

About SSP E.W. Scripps Company (The)

The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: